LFCM
BNTX icon

Long Focus Capital Management’s BioNTech BNTX Stock Holding History

Long Focus Capital Management’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-910,000
Closed -$104M – 103
2024
Q4 		$104M Buy
+910,000
New +$104M 3.36% 6

Other funds holding BNTX

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Long Focus Capital Management's BNTX Position: Q1 2026 in Review

Long Focus Capital Management increased its BioNTech (BNTX) stake by 23% in Q1 2026, buying an estimated $12M and bringing the position to 624,000 shares worth $55.5M. The position accounts for 1.46% of the portfolio, ranked #17.

Long Focus Capital Management first reported a position in BNTX in Q1 2025 and has held it in 5 quarters since. 272 funds tracked by Wall St. Rank hold BNTX as of Q1 2026.

  • Long Focus Capital Management held 624,000 shares of BioNTech worth $55.5M as of Q1 2026.
  • Long Focus Capital Management bought 116,345 BioNTech shares in Q1 2026, an estimated $12M.
  • BioNTech made up 1.46% of Long Focus Capital Management's portfolio in Q1 2026, its #17 holding.
  • Long Focus Capital Management first reported a position in BioNTech in Q1 2025 and has held it in 5 quarters since.
  • 272 funds tracked by Wall St. Rank held BioNTech as of Q1 2026.

Based on Long Focus Capital Management's 13F filing for Q1 2026, filed 15 May 2026.